The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid
Open accessAbstract
The HIV-1 capsid protein forms the conical core structure at the center of the mature virion. Capsid also binds the human peptidyl prolyl isomerase, cyclophilin A, thereby packaging the enzyme into the virion. Cyclophilin A subsequently performs an essential function in HIV-1 replication, possibly helping to disassemble the capsid core upon infection. We report the 2.36 A crystal structure of the N-terminal domain of HIV-1 capsid (residues 1-151) in complex with human cyclophilin A. A single exposed capsid loop (residues 85-93) binds in the enzyme's active site, and Pro-90 adopts an unprecedented trans conformation. The structure suggests how cyclophilin A can act as a sequence-specific binding protein and a nonspecific prolyl isomerase. In the crystal lattice, capsid molecules assemble into continuous planar strips. Side by side association of these strips may allow capsid to form the surface of the viral core. Cyclophilin A could then function by weakening the association between capsid strips, thereby promoting disassembly of the viral core.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A beta-hairpin is formed by the N-terminal residues in mature-like CA, stabilized by a salt bridge between the N-terminal proline and a conserved aspartate in helix 3”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [72]
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 1×
“Cyclophilin A is (bonds) 5 0.005 Å; RMSD (angles) 5 1.38; there are no w,c angles required for the replication of group M human immunodeficiency in the forbidden range (Laskowski et al., 1993).”
BackgroundInfluentialMOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011 · cited 1×
“(B) and (C) were prepared with MOLSCRIPT (Kraulis, 1991) and RASTER 3D (Bacon and Anderson, 1988). about CA151 residues 86 and 98, so that CypA and CA151 CypA active site groove.”
MethodJones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616 · cited 1×
“Mode of action of SDZ NIM spersed with model building using O (Jones et al., 1991).”
MethodLIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.2.127 · Cited by 5,731 · cited 1×
“Schematic representation of the CA151 and CypA interface (Wallace et al., 1995).”
BackgroundAMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127 · cited 1×
“Schreiber and Crabtree have proposed that CypA does not normally function as an enzyme in vivo However, it is possible that kcat/Km is similar to that of other substrates because kcat and Km have been(Schreiber and Crabtree, 1992).”
BackgroundImproved Fourier coefficients for maps using phases from partial structures with errors
Read, R. J. (1986) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767386099622 · Cited by 1,870
PROMOTIF—A program to identify and analyze structural motifs in proteins
Hutchinson, E. G., & Thornton, J. M. (1996) · Protein Science · doi:10.1002/pro.5560050204 · Cited by 1,043 · cited 1×
“The last six residues of both CA151 molecules are (A) Secondary structure of CA151 (Hutchinson and Thornton, 1996).”
BackgroundHuman Retroviruses and Aids - 1999
KUIKEN, C. L., & Foley, B. T. (1999) · doi:10.2172/1186019 · Cited by 952
Research works printed but not linked: 3
- Cowtan, 1994, ′dm′, Joint CCP, 34
- Gelderblom, H.R., Bauer, P.G.Özel, M., Höglund, S., Niedrig, M., Renz, H., Morath, B., Lundquist, P., NilssonÅ., Mattow, J., et al. (1992). Morphogenesis and morphology of human immunodeficiency virus. In Membrane Interactions of HIV, R.C. Aloia, and C.C. Curtain, eds. (New York: Wiley-Liss, Inc.), pp. 33–54.
- Otwinowski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing, L. Sawyer, N. Isaacs, and S. Bailey, eds. (Warrington, England: SERC Daresbury Laboratory), pp. 56–62.
Cited by
Sorted by citations
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967
“…A-Fc fragment 2.8 1300 2 Deisenhofer (1981) 1igc Protein G-Fab MOPC21 2.6 1350 14 Derrick & Wigley (1994) 1ak4 Cyclophilin-HIV capsid 2.4 1170 8 3 Gamble et al. (1996) 1efn Fyn SH3 domain-HIV Nef 2.5 1260 7 Lee et al. (1996) 1atn Actin-DNase I 2.8 1780 8 Kabsch et al. (1990) 2btf Actin-profilin…”
InfluentialAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677
Cis−Trans Isomerization of Organic Molecules and Biomolecules: Implications and Applications
Dugave, C., & Demange, L. (2003) · Chemical Reviews · doi:10.1021/cr0104375 · Cited by 1,033
HIV-1: Fifteen Proteins and an RNA
Frankel, A. D., & Young, J. A. T. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.1 · Cited by 913
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. F. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 869
Enzyme Dynamics During Catalysis
Eisenmesser, E. Z., Bosco, D. A., Akke, M., & Kern, D. (2002) · Science · doi:10.1126/science.1066176 · Cited by 732
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717
“Mutational analysis indicated that the domain responsible for CypA incorporation resided in the vicinity of Pro 90 (Franke et al., 1994b); this conclusion was confirmed by the cocrystallization of CA with CypA (Gamble et al., 1996).”
BackgroundMethodInfluentialRanganathan, R., Lu, K. P., Hunter, T. R., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 703
“In light of the multivalent nature of the bound sulfate ion, we propose that Pin1 will C-terminal to these residues (Gamble et al., 1996). preferentially catalyze isomerization of peptide bonds involving a minimal segment consisting of a P.Ser or P.Thr residue N-terminal to proline.”
BackgroundTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
HIV-1 assembly, release and maturation
Freed, E. O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3490 · Cited by 654
“Subsequent structural studies demonstrated that MA interacts directly with the negatively charged inositol headgroup of PtdIns(4,5)P2 (REFS 11,12).”
BackgroundInfluentialPeptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts
G�thel, S. F., & Marahiel, M. A. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050299 · Cited by 649
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake, D. K., Wang, H., McCutcheon, J. P., Sundquist, W. I., & Hill, C. P. (1997) · Science · doi:10.1126/science.278.5339.849 · Cited by 598
Self-citationForshey, B. M., von Schwedler, U. K., Sundquist, W. I., & Aiken, C. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5667-5677.2002 · Cited by 514
“Structural studies have revealed that CA consists of two distinct, globular domains connected by a flexible linker: an amino-terminal domain, composed of seven -helices and a -hairpin, and a carboxyl-terminal domain, composed of a 310 helix and four -helices (15, 16, 18, 29, 31).”
BackgroundSelf-citationThe structural biology of HIV assembly
Ganser‐Pornillos, B. K., Yeager, M. J., & Sundquist, W. I. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.02.001 · Cited by 500
Self-citationHIV and SIV CTL escape: implications for vaccine design
Goulder, P., & Watkins, D. I. (2004) · Nature reviews. Immunology · doi:10.1038/nri1417 · Cited by 502
“Modelling of these mutations supports this idea, because R264 seems to occupy a crucial position in the capsid protein, being situated centrally in helix-7 and seemingly directly mediating the dimerization of p24 Gag (the capsid protein”
BackgroundStructural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
“Details of the intermolecular interactions have been obtained from X-ray structural studies of the CA core-CypA complex (Gamble et al., 1996).”
BackgroundMethodInfluentialImage reconstructions of helical assemblies of the HIV-1 CA protein
Li, S., Hill, C. P., Sundquist, W. I., & Finch, J. T. (2000) · Nature · doi:10.1038/35030177 · Cited by 500
Self-citationChen, F., Liu, H., Sun, H., Pan, P., Li, Y., Li, D., & Hou, T. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp03670h · Cited by 464
Efficient docking of peptides to proteins without prior knowledge of the binding site
Hetényi, C., & van der Spoel, D. (2002) · Protein Science · doi:10.1110/ps.0202302 · Cited by 454
“The latter finding hints at the possibility of a combination of blind docking with fragment docking ( Friedman et al. 1994 ) and to studies of proteinprotein interactions.”
BackgroundHost Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
Bushman, F. D., Malani, N., Fernandes, J. D., D’Orso, I., Cagney, G., Diamond, T. L., Zhou, H., Hazuda, D. J., Espeseth, A. S., König, R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000437 · Cited by 464
“. Several genes known to encode products important for HIV replication were identified in the initial screen of Konig et al., which yielded 4,019 candidates, but were not further validated in the filtered data set of 293 proteins. These included Sp1, a transcription factor known to bind the HIV LTR; the HIV Gag bindin…”
BackgroundKelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C. P., Workman, C., Shaunak, S., Olson, K., Goulder, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.375 · Cited by 447
“It may also indicate that in vivo the mutation is only tolerable in subtype B viruses, all of which on the database have E260, when E260D and R264G mutations occur in the presence of L268.”
BackgroundInfluentialMartínez‐Picado, J., Prado, J. G., Fry, E. E., Pfafferott, K. J., Leslie, A. J., Chetty, S., Thobakgale, C., Honeyborne, I., Crawford, H., Matthews, P. C., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3617-3623.2006 · Cited by 447
“As with other epitopes associated with successful HIV/SIV control (4, 13, 14, 19), the capsid protein is a promising target for effective CTL, perhaps because of selection pressure against single escape mutations arising in the absence of linked compensatory changes.”
BackgroundHIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 499
“CA, which comprises independently folded N-terminal and C-terminal domains (NTD and CTD, respectively) connected by a flexible linke”
BackgroundFunctional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein
von Schwedler, U. K., Stray, K. M., Garrus, J. E., & Sundquist, W. I. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5439-5450.2003 · Cited by 421
“HIV-1 (4, 34, 38, 64), equine infectious anemia virus (47),”
BackgroundSelf-citationStructures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Shahzad‐ul‐Hussan, S., Stanfield, R. L., Robinson, J. E., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. J. S. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 359
“The latter binds to cyclophilin A (CypA), a peptidyl prolyl cis/trans isomerase of the host cell, which is incorporated into the HIV particle (Gamble et al., 1996).”
BackgroundProteolytic refolding of the HIV‐1 capsid protein amino‐terminus facilitates viral core assembly
von Schwedler, U. K., Stemmler, T. L., Klishko, V. Y., Li, S., Albertine, K. H., Davis, D. R., & Sundquist, W. I. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1555 · Cited by 337
“Guided by the crystal structure of CA151 (Gamble et al., 1996), we designed five point mutations that were expected to disrupt the amino-terminal capsid interface, but minimize other structural perturbations.”
BackgroundMethodInfluentialSelf-citationThe Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Liu, Z., Pan, Q., Ding, S., Qian, J., Xu, F., Zhou, J., Cen, S., Guo, F., & Liang, C. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.015 · Cited by 336
Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H., & Kräusslich, H.-G. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2846-2854.1998 · Cited by 336
“Structure determination of a fragment of HIV-1 CA (18, 41) revealed an N-terminal b-hairpin stabilized by hydrogen bonding involving the amino group of proline 1 of CA, which is only exposed after proteolytic cleavage (13, 18).”
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
Yurchenko, V., Zybarth, G., O’Connor, M. J., Dai, W. W., Franchin, G., Tang, H., Guo, H., Hung, H., Toole, B. P., Gallay, P. A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201593200 · Cited by 334
Structure of Full-Length HIV-1 CA: A Model for the Mature Capsid Lattice
Ganser-Pornillos, B. K., Cheng, A., & Yeager, M. (2007) · Cell · doi:10.1016/j.cell.2007.08.018 · Cited by 321
“…the HIV-1 CA NTD is shaped as an arrowhead, with seven a helices (numbered 1–7) and an amino-terminal b-hairpin (Berthet-Colominas et al., 1999; Gamble et al., 1996; Gitti et al., 1996), while the CTD is more globular, with a single-turn 3 10 -helix and four short a helices (numbered 8–11)…”
Schneidewind, A., Brockman, M. A., Yang, R., Adam, R. I., Li, B., Gall, S. L., Rinaldo, C. R., Craggs, S. L., Allgaier, R. L., Power, K. A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01543-07 · Cited by 315
“The underlying mechanism of this dependency on CypA remains unclear, although it has been suggested to be related to the regulation of capsid stability (33, 37), uncoating (35), or impairment of recognition of capsid by host restriction factors (71).”
BackgroundInfluentialAssembly Properties of the Human Immunodeficiency Virus Type 1 CA Protein
Ganser-Pornillos, B. K., von Schwedler, U. K., Stray, K. M., Aiken, C., & Sundquist, W. I. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2545-2552.2004 · Cited by 302
“important for infectivity and assembly (18, 52, 53, 56).”
BackgroundSelf-citationMatreyek, K. A., Yücel, S. S., Li, X., & Engelman, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003693 · Cited by 280
“…A (CypA) and the NUP358 cyclophilin homologous domain (CHD), both of which bind the cyclophilin binding loop protruding from the top of the CA NTD [39,40], or cleavage and polyadenylation specific factor 6 (CPSF6), which binds a hydrophobic pocket [41] located between a -helices 3 and 4 within…”
BackgroundHIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention
Blair, W. S., Pickford, C., Irving, S. L., Brown, D. G., Anderson, M. D., Bazin, R., Cao, J. Q., Ciaramella, G., Isaacson, J., Jackson, L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001220 · Cited by 291
Miura, T., Brockman, M. A., Schneidewind, A., Lobritz, M. A., Pereyra, F., Rathod, A., Block, B. L., Brumme, Z. L., Brumme, C. J., Baker, B. M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02265-08 · Cited by 294
“binding loop, which is just upstream of TW10 (18, 19), were”
BackgroundCampbell, S., & Rein, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2270-2279.1999 · Cited by 293
A Knowledge-Based Energy Function for Protein−Ligand, Protein−Protein, and Protein−DNA Complexes
Zhang, C., Liu, S., Zhu, Q., & Zhou, Y. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049314d · Cited by 291
Cyclophilin A regulates HIV‐1 infectivity, as demonstrated by gene targeting in human T cells
Braaten, D. C., & Luban, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1300 · Cited by 275
Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A
Brazin, K. N., Mallis, R. J., Fulton, D. B., & Andreotti, A. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042529199 · Cited by 275
Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas, M., Lohmann, V., Luban, J., & Bartenschlager, R. F. W. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000546 · Cited by 267
Kirmaier, A., Wu, F., Newman, R. M., Hall, L. R., Morgan, J. S., O’Connor, S. L., Marx, P. A., Meythaler, M., Goldstein, S. C., Buckler-White, A. J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000462 · Cited by 265
“. TRIM5CypA restriction of lentiviral infection involves specific binding to a peptide loop between helices 4 and 5 of the viral CA (also the binding site for cellular CypA)”
BackgroundMolecular recognition in the HIV-1 capsid/cyclophilin A complex 1 1Edited by J. A. Wells
Yoo, S., Myszka, D. G., Yeh, C.-Y., McMurray, M., Hill, C. P., & Sundquist, W. I. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1051 · Cited by 259
“Similarly, our recent CA 151 /CypA co-crystal structure revealed that capsid residues 85 to 93 make a series of favorable contacts in the CypA active site, with no other signi®cant CypA- CA or CypA-CypA interaction (Gamble et al., 1996).”
BackgroundMethodInfluentialSelf-citationBrockman, M. A., Schneidewind, A., Lahaie, M. P., Schmidt, A. G., Miura, T., DeSouza, I., Ryvkin, F., Derdeyn, C. A., Allen, S. A., Hunter, E., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01369-07 · Cited by 261
“Upon binding to CypA, alpha helices I, II, IV, and VI in the amino-terminal domain show significant movement (3, 31).”
BackgroundByeon, I.-J. L., Meng, X., Jung, J., Zhao, G., Yang, R., Ahn, J., Shi, J., Concel, J., Aiken, C., Zhang, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.010 · Cited by 253
Hexagonal assembly of a restricting TRIM5α protein
Ganser‐Pornillos, B. K., Chandrasekaran, V., Pornillos, O., Sodroski, J., Sundquist, W. I., & Yeager, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013426108 · Cited by 248
Self-citationCryo-electron microscopy reveals ordered domains in the immature HIV-1 particle
Fuller, S. D., Wilk, T., Gowen, B. E., Kräusslich, H., & Vogt, V. M. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00331-9 · Cited by 246
A conformational switch controlling HIV‐1 morphogenesis
Gross, I., Hohenberg, H., Wilk, T., Wiegers, K. J., Grättinger, M., Müller, B., Fuller, S., & Kräusslich, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.103 · Cited by 241
“…on molecular modeling, the C-terminus of CA and adjacent SP1 residues have been proposed to form a continuous α-helix (Accola et al., 1998), while this region was disordered in the structures of CA determined to date (Gamble et al., 1996; Berthet-Colominas et al., 1999; Worthylake et al., 1999).”
BackgroundStructures of the HIV-1 capsid protein dimerization domain at 2.6 Å resolution
Worthylake, D. K., Wang, H., Yoo, S., Sundquist, W. I., & Hill, C. P. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998007689 · Cited by 235
“The three-dimensional structure of the N-terminal domain of the HIV-1 capsid has also been determined in solution (Gitti et al., 1996) and in crystals as complexes with an Fab fragment (Momany et al., 1996) and cyclophilin A (Gamble et al., 1996).”
Self-citationInsights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases
Fanghänel, J. (2004) · Frontiers in bioscience · doi:10.2741/1494 · Cited by 232
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis
Jacques, D. A., McEwan, W. A., Hilditch, L., Price, A. J., Towers, G. J., & James, L. C. (2016) · Nature · doi:10.1038/nature19098 · Cited by 234
Yang, F., Robotham, J. M., Nelson, H. B., Irsigler, A., Kenworthy, R., & Tang, H. (2008) · Journal of Virology · doi:10.1128/jvi.02614-07 · Cited by 231
“The well-characterized crystal structure of the CyPA-CA complex (9, 41, 48) may provide relevant insight and guidance for further characterization of the CyPANS5B interface.”
BackgroundCatalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A
Bosco, D. A., Eisenmesser, E. Z., Pochapsky, S. S., Sundquist, W. I., & Kern, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082100499 · Cited by 226
Self-citationSpecific inhibition of hepatitis C virus replication by cyclosporin A
Nakagawa, M., Sakamoto, N., Enomoto, N., Tanabe, Y., Kanazawa, N., Koyama, T., Kurosaki, M., Maekawa, S., Yamashiro, T., Chen, C.-H., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.080 · Cited by 229
Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity
Sokolskaja, E., Sayah, D. M., & Luban, J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12800-12808.2004 · Cited by 218
“X-ray and nuclear magnetic resonance analysis of CypA in complex with various Gag fragments confirmed that these residues participate in direct protein-protein interactions (27, 40, 47, 51, 57).”
BackgroundFischer, G. S., & Aumüller, T. (2003) · Springer eBooks · doi:10.1007/s10254-003-0011-3 · Cited by 225
Antiviral Inhibition of the HIV-1 Capsid Protein
Tang, C., Loeliger, E., Kinde, I., Kyere, S., Mayo, K., Barklis, E., Sun, Y., Huang, M., & Summers, M. F. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00289-4 · Cited by 218
Retrovirus Restriction Factors
Goff, S. P. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.12.001 · Cited by 215
Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions
Dettenhofer, M., & Yu, X.-F. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1460-1467.1999 · Cited by 239
“Analysis of virions obtained from the peak fractions of an OptiPrep velocity gradient indicated that viral Gag proteins CAp24, MAp17, and NCp7/p6Gag contributed more than 80% of the total protein content (Fig.”
BackgroundInfluentialImmunophilins: for the love of proteins
Barik, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6215-3 · Cited by 218
Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein
Tang, C., Ndassa, Y., & Summers, M. F. (2002) · Nature Structural Biology · doi:10.1038/nsb806 · Cited by 205
“The mature HIV-1 CA protein consists of the N-terminal 'core' (CA N ) and C-terminal dimerization (CA C ) domains, which are folded independently and connected by a flexible linke”
BackgroundEnzymes: An integrated view of structure, dynamics and function
Agarwal, P. K. (2006) · Microbial Cell Factories · doi:10.1186/1475-2859-5-2 · Cited by 204
“The proteinprotein complex between CypA and CA has been the subject of many experimental studies [16,34-37].”
BackgroundEarly steps of retrovirus replicative cycle
Nisole, S., & Saı̈b, A. (2004) · Retrovirology · doi:10.1186/1742-4690-1-9 · Cited by 230
“Finally, the cellular protein cyclophilin A (CypA), which is incorporated into virions through its interaction with viral capsid [111-113], has been shown to play a critical role in the correct disassembly of the HIV-1 cores early after infection [114], since particles lacking CypA display a defect between entry and r…”
BackgroundAccola, M. A., Höglund, S., & Göttlinger, H. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2072-2078.1998 · Cited by 196
“An exposed loop region between two a-helices interacts with the prolyl isomerase cyclophilin A (14), which leads to the incorporation of the cellular enzyme into virions (13, 48).”
BackgroundHatziioannou, T., Pérez-Caballero, D., Cowan, S., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.176-183.2005 · Cited by 191
“In addition, mutation of residues G89 or P90 of HIV-1 CA, which constitute the core of the CypA binding site (16, 46), both disrupt CypA binding and confer a substantial replication defect in human cells (2, 9, 12, 15), consistent with the notion that the CypA-CA interaction is important for HIV-1 replication.”
BackgroundLiu, S., Zhang, C., Zhou, H., & Zhou, Y. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20019 · Cited by 193
Extreme Genetic Fragility of the HIV-1 Capsid
Rihn, S. J., Wilson, S. J., Loman, N. J., Alim, M., Bakker, S. E., Bhella, D., Gifford, R. J., Rixon, F. J., & Bieniasz, P. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003461 · Cited by 199
Berthet-Colominas, C., Monaco, S., Novelli, A., Sibaı̈, G., Mallet, F., & Cusack, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1124 · Cited by 191
“C interfaces have been described (Gamble et al., 1996, 1997; Momany et al., 1996).”
BackgroundMethodResultInfluentialIndependent genesis of chimeric TRIM5-cyclophilin proteins in two primate species
Virgen, C. A., Kratovac, Z., Bieniasz, P. D., & Hatziioannou, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709258105 · Cited by 186
High-resolution structure of a retroviral capsid hexameric amino-terminal domain
Mortuza, G. B., Haire, L. F., Stevens, A., Smerdon, S. J., Stoye, J. P., & Taylor, I. A. (2004) · Nature · doi:10.1038/nature02915 · Cited by 185
“However, structures of the mature forms of viral capsid protein NTDs have all been determined in monomeric or a non-biologically relevant dimeric for”
BackgroundHost cyclophilin A mediates HIV‐1 attachment to target cells via heparans
Saphire, A. C. S., Bobardt, M. D., & Gallay, P. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6771 · Cited by 180
“Crystal structure analysis reveals that a proline-rich stretch of the single exposed loop of HIV-1 CA interacts with the catalytic domain of the isomerase (Gamble et al., 1996).”
BackgroundHuman immunodeficiency virus type 1 assembly, release, and maturation
Adamson, C. S., & Freed, E. O. (2007) · Advances in Pharmacology · doi:10.1016/s1054-3589(07)55010-6 · Cited by 179
Restriction of HIV-1 and other retroviruses by TRIM5
Ganser-Pornillos, B. K., & Pornillos, O. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0225-2 · Cited by 163
Gross, I., Hohenberg, H., Huckhagel, C., & Kräusslich, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4798-4810.1998 · Cited by 173
“Structural analysis of CA-CypA cocrystals (at a CA-to-CypA ratio of 1:1) showed that CypA binding may inhibit interactions between planar CA strips, thereby preventing the formation of higher-order structures (14).”
BackgroundMethodInfluentialThe HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor
Ternois, F., Sticht, J., Duquerroy, S., Kräusslich, H., & Rey, F. A. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb967 · Cited by 176
Structural basis of macromolecular recognition
Wodak, S. J., & Janin, J. (2002) · Advances in protein chemistry · doi:10.1016/s0065-3233(02)61001-0 · Cited by 172
Stereospecific Interactions of Proline Residues in Protein Structures and Complexes
Bhattacharyya, R., & Chakrabarti, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00759-9 · Cited by 172
Yeager, M., Wilson-Kubalek, E. M., Weiner, S. G., Brown, P. O., & Rein, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7299 · Cited by 189
High-resolution global peptide-protein docking using fragments-based PIPER-FlexPepDock
Alam, N., Goldstein, O., Xia, B., Porter, K. A., Kozakov, D., & Schueler‐Furman, O. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005905 · Cited by 171
Cimarelli, A., & Luban, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5388-5401.1999 · Cited by 166
HIV-1 uncoating: connection to nuclear entry and regulation by host proteins
Ambrose, Z., & Aiken, C. (2014) · Virology · doi:10.1016/j.virol.2014.02.004 · Cited by 187
Zardecki, C., Dutta, S., Goodsell, D. S., Voigt, M., & Burley, S. K. (2016) · Journal of Chemical Education · doi:10.1021/acs.jchemed.5b00404 · Cited by 164
The SARS-CoV nucleocapsid protein: A protein with multifarious activities
Surjit, M., & Lal, S. K. (2007) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2007.07.004 · Cited by 160
“Notable is the fact that HIV-1 gag also binds with human cyclophylin A and this interaction is crucial for HIV infection (Gamble et al., 1996) .”
BackgroundGatanaga, H., Suzuki, Y., Tsang, H., Yoshimura, K., Kavlick, M. F., Nagashima, K., Gorelick, R. J., Mardy, S., Tang, C., Summers, M. F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108005200 · Cited by 156
Cyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site
Liu, C., Perilla, J. R., Ning, J., Lu, M., Hou, G., Ramalho, R., Himes, B. A., Zhao, G., Bedwell, G. J., Byeon, I. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms10714 · Cited by 156
Nuclear landscape of HIV-1 infection and integration
Lušić, M., & Siliciano, R. F. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.162 · Cited by 168
Structural insights into the catalytic mechanism of cyclophilin A
Howard, B. R., Vajdos, F. F., Li, S., Sundquist, W. I., & Hill, C. P. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb927 · Cited by 149
Self-citationCyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection
Luban, J. (2007) · Journal of Virology · doi:10.1128/jvi.01519-06 · Cited by 147
“CypA binding is enhanced by CA multimerization (14, 17), though binding to monomeric CA can be detected at high protein concentrations (29).”
BackgroundCyclophilin A is required for TRIM5α-mediated resistance to HIV-1 in Old World monkey cells
Berthoux, L., Sebastian, S., Sokolskaja, E., & Luban, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505659102 · Cited by 146
Schneidewind, A., Brockman, M. A., Sidney, J., Wang, Y. E., Chen, H., Suscovich, T. J., Li, B., Adam, R. I., Allgaier, R. L., Mothé, B. R., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02356-07 · Cited by 146
“Binding of CypA to the viral capsid is normally necessary for efficient infection by HIV-1 and is believed to regulate the uncoating process or to impair recognition of the capsid by host restriction factors (10, 19, 21, 58).”
BackgroundConformation of the HIV-1 Gag Protein in Solution
Datta, S. A. K., Curtis, J. E., Ratcliff, W., Clark, P. K., Crist, R. M., Lebowitz, J., Krueger, S., & Rein, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.073 · Cited by 145
Lentivirus Replication and Regulation
Tang, H., Kuhen, K., & Wong‐Staal, F. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.133 · Cited by 144
Novel approaches to inhibiting HIV-1 replication
Adamson, C. S., & Freed, E. O. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.009 · Cited by 149
“The CypA portion of TRIM-Cyp binds CA (Gamble et al., 1996; Luban et al., 1993) and disruption of this interaction abolishes the restriction activity of TRIM-Cyp (Towers et al., 2003).”
BackgroundTang, S., Murakami, T., Agresta, B. E., Campbell, S., Freed, E. O., & Levin, J. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9357-9366.2001 · Cited by 142
Structures of radial spokes and associated complexes important for ciliary motility
Gui, M., Ma, M., Sze-Tu, E., Wang, X., Koh, F., Zhong, E. D., Berger, B., Davis, J. H., Dutcher, S. K., Zhang, R., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00530-0 · Cited by 135
Liao, C., Kuang, Y., Liu, H., Zheng, Y., & Su, B. (2007) · AIDS · doi:10.1097/01.aids.0000304692.09143.1b · Cited by 138
“Therefore, this isoform may not have any restrictive effects on HIV-1 infection either [30,31].”
BackgroundOwens, C. M., Yang, P. C., Göttlinger, H. G., & Sodroski, J. (2002) · Journal of Virology · doi:10.1128/jvi.77.1.726-731.2003 · Cited by 137
The Molecular Biology of SARS Coronavirus
Satija, N., & Lal, S. K. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1408.002 · Cited by 134
“28 Hence CypA interaction with N protein may provide new hints about how SARS CoV infects host cells.”
BackgroundInteractions between HIV-1 Gag Molecules in Solution: An Inositol Phosphate-mediated Switch
Datta, S. A. K., Zhao, Z., Clark, P. K., Tarasov, S. G., Alexandratos, J. N., Campbell, S. J., Kvaratskhelia, M., Lebowitz, J., & Rein, A. R. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.072 · Cited by 132
Metadata
- Authors
- Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., & Hill, C. P.
- Affiliations
- University of Utah (US)
- Corresponding author
- Hill, Christopher P
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-12
- Volume
- 87
- Issue
- 7
- Pages
- 1285-1294
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2121753315
- Cited by
- 706
- References
- 59
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 7 · 2023: 18 · 2022: 20 · 2021: 26 · 2020: 16 · 2019: 12 · 2018: 23 · 2017: 21 · 2016: 29 · 2015: 22 · 2014: 25 · 2013: 32 · 2012: 24
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- cyclophilin A, HIV-1 capsid, peptidyl-prolyl isomerase, protein-protein complex, capsid disassembly, viral core, capsid assembly, HIV-1 replication
- MeSH terms
- Amino Acid Isomerases, Capsid, Carrier Proteins, Humans, Models, Molecular, Protein Binding, Virion, HIV-1, Gene Products, gag, Protein Structure, Tertiary, Crystallography, X-Ray, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review